Cited by 790

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

The Role of the Transcription Factor CREB in Immune Function

Wen, Andy Y, Sakamoto, Kathleen M, Miller, Lloyd S·2010·The Journal of Immunology

Abstract

CREB is a transcription factor that regulates diverse cellular responses, including proliferation, survival, and differentiation. CREB is induced by a variety of growth factors and inflammatory signals and subsequently mediates the transcription of genes containing a cAMP-responsive element. Several immune-related genes possess this cAMP-responsive element, including IL-2, IL-6, IL-10, and TNF-α. In addition, phosphorylated CREB has been proposed to directly inhibit NF-κB activation by blocking the binding of CREB binding protein to the NF-κB complex, thereby limiting proinflammatory responses. CREB also induces an antiapoptotic survival signal in monocytes and macrophages. In T and B cells, CREB activation promotes proliferation and survival and differentially regulates Th1, Th2, and Th17 responses. Finally, CREB activation is required for the generation and maintenance of regulatory T cells. This review summarizes current advances involving CREB in immune function—a role that is continually being defined.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.4049/jimmunol.1001829

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 67

  1. Shaywitz, 1999, CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals, Annu. Rev. Biochem., 68, 821, 10.1146/annurev.biochem.68.1.821 · DOI
  2. Mayr, 2001, Transcriptional regulation by the phosphorylation-dependent factor CREB, Nat. Rev. Mol. Cell Biol., 2, 599, 10.1038/35085068 · DOI · Paper page
  3. Sakamoto, 2009, CREB in the pathophysiology of cancer: implications for targeting transcription factors for cancer therapy, Clin. Cancer Res., 15, 2583, 10.1158/1078-0432.CCR-08-1137 · DOI
  4. Brindle, 1993, Protein-kinase-A-dependent activator in transcription factor CREB reveals new role for CREM repressors, Nature, 364, 821, 10.1038/364821a0 · DOI
  5. Enslen, 1995, Phosphorylation of CREB by CaM-kinase IV activated by CaM-kinase IV kinase, Biochem. Biophys. Res. Commun., 207, 1038, 10.1006/bbrc.1995.1289 · DOI
  6. Gubina, 2001, betac cytokine receptor-induced stimulation of cAMP response element binding protein phosphorylation requires protein kinase C in myeloid cells: a novel cytokine signal transduction cascade, J. Immunol., 167, 4303, 10.4049/jimmunol.167.8.4303 · DOI
  7. Conkright, 2003, TORCs: transducers of regulated CREB activity, Mol. Cell, 12, 413, 10.1016/j.molcel.2003.08.013 · DOI
  8. Impey, 2004, Defining the CREB regulon: a genome-wide analysis of transcription factor regulatory regions, Cell, 119, 1041
  9. Brenner, 2003, cAMP-induced Interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation, J. Biol. Chem., 278, 5597, 10.1074/jbc.M207448200 · DOI
  10. Hughes-Fulford, 2005, Early immune response and regulation of IL-2 receptor subunits, Cell. Signal., 17, 1111, 10.1016/j.cellsig.2004.12.016 · DOI
  11. Takeuchi, 2010, Pattern recognition receptors and inflammation, Cell, 140, 805, 10.1016/j.cell.2010.01.022 · DOI · Paper page
  12. Medzhitov, 2010, Inflammation 2010: new adventures of an old flame, Cell, 140, 771, 10.1016/j.cell.2010.03.006 · DOI
  13. Ghosh, 2008, New regulators of NF-kappaB in inflammation, Nat. Rev. Immunol., 8, 837, 10.1038/nri2423 · DOI
  14. Medzhitov, 2009, Transcriptional control of the inflammatory response, Nat. Rev. Immunol., 9, 692, 10.1038/nri2634 · DOI · Paper page
  15. Ollivier, 1996, Elevated cyclic AMP inhibits NF-kappaB-mediated transcription in human monocytic cells and endothelial cells, J. Biol. Chem., 271, 20828, 10.1074/jbc.271.34.20828 · DOI
  16. Parry, 1997, Role of cyclic AMP response element-binding protein in cyclic AMP inhibition of NF-kappaB-mediated transcription, J. Immunol., 159, 5450, 10.4049/jimmunol.159.11.5450 · DOI
  17. Pigazzi, 2009, miR-34b targets cyclic AMP-responsive element binding protein in acute myeloid leukemia, Cancer Res., 69, 2471, 10.1158/0008-5472.CAN-08-3404 · DOI
  18. Park, 2005, Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis—CREB and NF-kappaB as key regulators, Immunity, 23, 319, 10.1016/j.immuni.2005.08.010 · DOI
  19. Hsu, 2004, The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4, Nature, 428, 341, 10.1038/nature02405 · DOI
  20. Agarwal, 2009, Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase, Nature, 460, 98, 10.1038/nature08123 · DOI
  21. Cheng, 2008, CREB is a critical regulator of normal hematopoiesis and leukemogenesis, Blood, 111, 1182, 10.1182/blood-2007-04-083600 · DOI
  22. Kwon, 2000, Granulocyte-macrophage colony-stimulating factor stimulation results in phosphorylation of cAMP response element-binding protein through activation of pp90RSK, Blood, 95, 2552, 10.1182/blood.V95.8.2552 · DOI
  23. Tschopp, 2010, NLRP3 inflammasome activation: The convergence of multiple signalling pathways on ROS production?, Nat. Rev. Immunol., 10, 210, 10.1038/nri2725 · DOI
  24. Gavala, 2008, The nucleotide receptor P2RX7 mediates ATP-induced CREB activation in human and murine monocytic cells, J. Leukoc. Biol., 84, 1159, 10.1189/jlb.0907612 · DOI
  25. Potucek, 2006, Purinergic receptors modulate MAP kinases and transcription factors that control microglial inflammatory gene expression, Neurochem. Int., 49, 204, 10.1016/j.neuint.2006.04.005 · DOI
  26. Brautigam, 2005, Purinergic receptor modulation of BV-2 microglial cell activity: potential involvement of p38 MAP kinase and CREB, J. Neuroimmunol., 166, 113, 10.1016/j.jneuroim.2005.05.012 · DOI
  27. Bowdish, 2004, The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes, J. Immunol., 172, 3758, 10.4049/jimmunol.172.6.3758 · DOI
  28. Yu, 2007, Host defense peptide LL-37, in synergy with inflammatory mediator IL-1beta, augments immune responses by multiple pathways, J. Immunol., 179, 7684, 10.4049/jimmunol.179.11.7684 · DOI
  29. Saraiva, 2010, The regulation of IL-10 production by immune cells, Nat. Rev. Immunol., 10, 170, 10.1038/nri2711 · DOI
  30. Boonstra, 2006, Macrophages and myeloid dendritic cells, but not plasmacytoid dendritic cells, produce IL-10 in response to MyD88- and TRIF-dependent TLR signals, and TLR-independent signals, J. Immunol., 177, 7551, 10.4049/jimmunol.177.11.7551 · DOI
  31. Netea, 2004, Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells, J. Immunol., 172, 3712, 10.4049/jimmunol.172.6.3712 · DOI
  32. Ananieva, 2008, The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling, Nat. Immunol., 9, 1028, 10.1038/ni.1644 · DOI
  33. Martin, 2005, Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3, Nat. Immunol., 6, 777, 10.1038/ni1221 · DOI
  34. Brightbill, 2000, A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages, J. Immunol., 164, 1940, 10.4049/jimmunol.164.4.1940 · DOI
  35. Chan, 2009, A role for glycogen synthase kinase-3 in antagonizing mycobacterial immune evasion by negatively regulating IL-10 induction, J. Leukoc. Biol., 86, 283, 10.1189/jlb.0708442 · DOI
  36. Tone, 2000, IL-10 gene expression is controlled by the transcription factors Sp1 and Sp3, J. Immunol., 165, 286, 10.4049/jimmunol.165.1.286 · DOI · Paper page
  37. Kelly, 2010, Calcium-activated pathways and oxidative burst mediate zymosan-induced signaling and IL-10 production in human macrophages, J. Immunol., 184, 5545, 10.4049/jimmunol.0901293 · DOI
  38. Gee, 2007, IL-10 regulation by HIV-Tat in primary human monocytic cells: involvement of calmodulin/calmodulin-dependent protein kinase-activated p38 MAPK and Sp-1 and CREB-1 transcription factors, J. Immunol., 178, 798, 10.4049/jimmunol.178.2.798 · DOI
  39. Gee, 2006, Intracellular HIV-Tat expression induces IL-10 synthesis by the CREB-1 transcription factor through Ser133 phosphorylation and its regulation by the ERK1/2 MAPK in human monocytic cells, J. Biol. Chem., 281, 31647
  40. Li, 2007, A role for mitogen-activated protein kinase and Ets-1 in the induction of interleukin-10 transcription by human immunodeficiency virus-1 Tat, Immunology, 121, 337, 10.1111/j.1365-2567.2007.02580.x · DOI
  41. Akridge, 1994, IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages, J. Immunol., 153, 5782, 10.4049/jimmunol.153.12.5782 · DOI
  42. Zhou, 2001, IL-10 inhibits apoptosis of promyeloid cells by activating insulin receptor substrate-2 and phosphatidylinositol 3′-kinase, J. Immunol., 167, 4436, 10.4049/jimmunol.167.8.4436 · DOI
  43. Schroder, 2004, Interferon-gamma: an overview of signals, mechanisms and functions, J. Leukoc. Biol., 75, 163, 10.1189/jlb.0603252 · DOI · Paper page
  44. Hu, 2006, IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins, Immunity, 24, 563, 10.1016/j.immuni.2006.02.014 · DOI
  45. Grimes, 2001, CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium, J. Neurochem., 78, 1219, 10.1046/j.1471-4159.2001.00495.x · DOI
  46. Solomou, 2001, Protein kinase C-theta participates in the activation of cyclic AMP-responsive element-binding protein and its subsequent binding to the -180 site of the IL-2 promoter in normal human T lymphocytes, J. Immunol., 166, 5665, 10.4049/jimmunol.166.9.5665 · DOI
  47. Yeh, 2001, Novel CD28-responsive enhancer activated by CREB/ATF and AP-1 families in the human interleukin-2 receptor alpha-chain locus, Mol. Cell. Biol., 21, 4515, 10.1128/MCB.21.14.4515-4527.2001 · DOI
  48. Anderson, 1989, Transcription from a murine T-cell receptor V beta promoter depends on a conserved decamer motif similar to the cyclic AMP response element, Mol. Cell. Biol., 9, 4835
  49. Gao, 1993, Functional importance of the cyclic AMP response element-like decamer motif in the CD8 alpha promoter, J. Immunol., 150, 4376, 10.4049/jimmunol.150.10.4376 · DOI
  50. Gupta, 1994, CD3 delta enhancer. CREB interferes with the function of a murine CD3-delta A binding factor (M delta AF), J. Immunol., 152, 3895, 10.4049/jimmunol.152.8.3895 · DOI
  51. Barton, 1996, Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB, Nature, 379, 81, 10.1038/379081a0 · DOI
  52. Zhang, 2000, Defective Th function induced by a dominant-negative cAMP response element binding protein mutation is reversed by Bcl-2, J. Immunol., 165, 1762, 10.4049/jimmunol.165.4.1762 · DOI
  53. Yano, 2003, Effect of promoter methylation on the regulation of IFN-gamma gene during in vitro differentiation of human peripheral blood T cells into a Th2 population, J. Immunol., 171, 2510, 10.4049/jimmunol.171.5.2510 · DOI
  54. Pasquinelli, 2009, IFN-gamma production during active tuberculosis is regulated by mechanisms that involve IL-17, SLAM, and CREB, J. Infect. Dis., 199, 661, 10.1086/596742 · DOI
  55. Grady, 2004, Cyclic adenosine 5′-monophosphate response element binding protein plays a central role in mediating proliferation and differentiation downstream of the pre-TCR complex in developing thymocytes, J. Immunol., 173, 1802, 10.4049/jimmunol.173.3.1802 · DOI
  56. Muthusamy, 1998, A protein kinase C-, Ras-, and RSK2-dependent signal transduction pathway activates the cAMP-responsive element-binding protein transcription factor following T cell receptor engagement, J. Biol. Chem., 273, 22841, 10.1074/jbc.273.35.22841 · DOI
  57. Yu, 2001, Multiple signals required for cyclic AMP-responsive element binding protein (CREB) binding protein interaction induced by CD3/CD28 costimulation, J. Immunol., 166, 284, 10.4049/jimmunol.166.1.284 · DOI
  58. Hsueh, 1997, CD28-costimulation activates cyclic AMP-responsive element-binding protein in T lymphocytes, J. Immunol., 158, 85, 10.4049/jimmunol.158.1.85 · DOI
  59. Kaiser, 2007, MSK regulate TCR-induced CREB phosphorylation but not immediate early gene transcription, Eur. J. Immunol., 37, 2583, 10.1002/eji.200636606 · DOI
  60. Sakaguchi, 2010, FOXP3+ regulatory T cells in the human immune system, Nat. Rev. Immunol., 10, 490, 10.1038/nri2785 · DOI
  61. Polansky, 2008, DNA methylation controls Foxp3 gene expression, Eur. J. Immunol., 38, 1654, 10.1002/eji.200838105 · DOI
  62. Polansky, 2010, Methylation matters: binding of Ets-1 to the demethylated Foxp3 gene contributes to the stabilization of Foxp3 expression in regulatory T cells, J. Mol. Med., 88, 1029, 10.1007/s00109-010-0642-1 · DOI
  63. Kim, 2007, CREB/ATF-dependent T cell receptor-induced FoxP3 gene expression: a role for DNA methylation, J. Exp. Med., 204, 1543, 10.1084/jem.20070109 · DOI
  64. Ruan, 2009, Development of Foxp3(+) regulatory t cells is driven by the c-Rel enhanceosome, Immunity, 31, 932, 10.1016/j.immuni.2009.10.006 · DOI
  65. Yasuda, 2008, Erk kinases link pre-B cell receptor signaling to transcriptional events required for early B cell expansion, Immunity, 28, 499, 10.1016/j.immuni.2008.02.015 · DOI
  66. Blois, 2004, B cell receptor-induced cAMP-response element-binding protein activation in B lymphocytes requires novel protein kinase Cdelta, J. Biol. Chem., 279, 30123, 10.1074/jbc.M402793200 · DOI
  67. Smale, 2010, Seq-ing LPS-induced enhancers, Immunity, 32, 296, 10.1016/j.immuni.2010.03.011 · DOI

Cited by

Sorted by citations

See all 790

Metadata

Authors
Wen, A. Y., Sakamoto, K. M., & Miller, L. S.
Affiliations
  • Division of Pediatric Critical Care, University of California Los Angeles , Los Angeles, CA, 90095
  • Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of California Los Angeles , Los Angeles, CA, 90095
  • Division of Dermatology, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles , Los Angeles, CA, 90095
Venue
The Journal of Immunology
Published
2010-12-01
Volume
185
Issue
11
Pages
6413-6419
ISSN
  • 0022-1767
  • 1550-6606
Cited by
790
References
2
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review